436 related articles for article (PubMed ID: 8632491)
1. The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry.
Sjögren S; Inganäs M; Norberg T; Lindgren A; Nordgren H; Holmberg L; Bergh J
J Natl Cancer Inst; 1996 Feb; 88(3-4):173-82. PubMed ID: 8632491
[TBL] [Abstract][Full Text] [Related]
2. The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer.
Linderholm BK; Lindahl T; Holmberg L; Klaar S; Lennerstrand J; Henriksson R; Bergh J
Cancer Res; 2001 Mar; 61(5):2256-60. PubMed ID: 11280795
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of p53 genetic changes in colorectal cancer.
Kressner U; Inganäs M; Byding S; Blikstad I; Påhlman L; Glimelius B; Lindmark G
J Clin Oncol; 1999 Feb; 17(2):593-9. PubMed ID: 10080604
[TBL] [Abstract][Full Text] [Related]
4. Combined Immunohistochemistry of PLK1, p21, and p53 for Predicting TP53 Status: An Independent Prognostic Factor of Breast Cancer.
Watanabe G; Ishida T; Furuta A; Takahashi S; Watanabe M; Nakata H; Kato S; Ishioka C; Ohuchi N
Am J Surg Pathol; 2015 Aug; 39(8):1026-34. PubMed ID: 26171916
[TBL] [Abstract][Full Text] [Related]
5. Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection of p53 gene mutations using cDNA sequencing in human breast tumors.
Norberg T; Lennerstrand J; Inganäs M; Bergh J
Int J Cancer; 1998 Aug; 79(4):376-83. PubMed ID: 9699530
[TBL] [Abstract][Full Text] [Related]
6. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer.
Allred DC; Clark GM; Elledge R; Fuqua SA; Brown RW; Chamness GC; Osborne CK; McGuire WL
J Natl Cancer Inst; 1993 Feb; 85(3):200-6. PubMed ID: 8423624
[TBL] [Abstract][Full Text] [Related]
7. p53 mutations and overexpression in locally advanced breast cancers.
Faille A; De Cremoux P; Extra JM; Linares G; Espie M; Bourstyn E; De Rocquancourt A; Giacchetti S; Marty M; Calvo F
Br J Cancer; 1994 Jun; 69(6):1145-50. PubMed ID: 8198984
[TBL] [Abstract][Full Text] [Related]
8. Distinct prognostic values of p53 mutations and loss of estrogen receptor and their cumulative effect in primary breast cancers.
Takahashi M; Tonoki H; Tada M; Kashiwazaki H; Furuuchi K; Hamada J; Fujioka Y; Sato Y; Takahashi H; Todo S; Sakuragi N; Moriuchi T
Int J Cancer; 2000 Jan; 89(1):92-9. PubMed ID: 10719737
[TBL] [Abstract][Full Text] [Related]
9. p53 as an independent prognostic marker in lymph node-negative breast cancer patients.
Silvestrini R; Benini E; Daidone MG; Veneroni S; Boracchi P; Cappelletti V; Di Fronzo G; Veronesi U
J Natl Cancer Inst; 1993 Jun; 85(12):965-70. PubMed ID: 8496982
[TBL] [Abstract][Full Text] [Related]
10. Patterns of p53 gene mutations in head and neck cancer: full-length gene sequencing and results of primary radiotherapy.
Saunders ME; MacKenzie R; Shipman R; Fransen E; Gilbert R; Jordan RC
Clin Cancer Res; 1999 Sep; 5(9):2455-63. PubMed ID: 10499619
[TBL] [Abstract][Full Text] [Related]
11. p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment.
Caleffi M; Teague MW; Jensen RA; Vnencak-Jones CL; Dupont WD; Parl FF
Cancer; 1994 Apr; 73(8):2147-56. PubMed ID: 8156519
[TBL] [Abstract][Full Text] [Related]
12. Improving the detection of p53 mutations in breast cancer by use of the FASAY, a functional assay.
Duddy PM; Hanby AM; Barnes DM; Camplejohn RS
J Mol Diagn; 2000 Aug; 2(3):139-44. PubMed ID: 11229518
[TBL] [Abstract][Full Text] [Related]
13. TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting.
Fountzilas G; Giannoulatou E; Alexopoulou Z; Zagouri F; Timotheadou E; Papadopoulou K; Lakis S; Bobos M; Poulios C; Sotiropoulou M; Lyberopoulou A; Gogas H; Pentheroudakis G; Pectasides D; Koutras A; Christodoulou C; Papandreou C; Samantas E; Papakostas P; Kosmidis P; Bafaloukos D; Karanikiotis C; Dimopoulos MA; Kotoula V
Oncotarget; 2016 May; 7(22):32731-53. PubMed ID: 27129168
[TBL] [Abstract][Full Text] [Related]
14. Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer.
Berns EM; van Staveren IL; Look MP; Smid M; Klijn JG; Foekens JA
Br J Cancer; 1998 Apr; 77(7):1130-6. PubMed ID: 9569050
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of P53 gene mutations in a large series of node-negative breast cancer patients.
Falette N; Paperin MP; Treilleux I; Gratadour AC; Peloux N; Mignotte H; Tooke N; Löfman E; Inganäs M; Bremond A; Ozturk M; Puisieux A
Cancer Res; 1998 Apr; 58(7):1451-5. PubMed ID: 9537247
[TBL] [Abstract][Full Text] [Related]
16. The p53 gene in soft tissue sarcomas: prognostic value of DNA sequencing versus immunohistochemistry.
Taubert H; Würl P; Bache M; Meye A; Berger D; Holzhausen HJ; Hinze R; Schmidt H; Rath FW
Anticancer Res; 1998; 18(1A):183-7. PubMed ID: 9568075
[TBL] [Abstract][Full Text] [Related]
17. Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value.
Kovach JS; Hartmann A; Blaszyk H; Cunningham J; Schaid D; Sommer SS
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1093-6. PubMed ID: 8577720
[TBL] [Abstract][Full Text] [Related]
18. p53 mutation found to be a significant prognostic indicator in distal colorectal cancer.
Okubo R; Masuda H; Nemoto N
Oncol Rep; 2001; 8(3):509-14. PubMed ID: 11295071
[TBL] [Abstract][Full Text] [Related]
19. Interest of investigating p53 status in breast cancer by four different methods.
Thirion A; Rouanet P; Thezenas S; Detournay D; Grenier J; Lopez-Crapez E
Oncol Rep; 2002; 9(6):1167-72. PubMed ID: 12375013
[TBL] [Abstract][Full Text] [Related]
20. p53 Status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings.
Jansson T; Inganäs M; Sjögren S; Norberg T; Lindgren A; Holmberg L; Bergh J
J Clin Oncol; 1995 Nov; 13(11):2745-51. PubMed ID: 7595733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
